According to a new report by UnivDatos Market Insights, the Elastography Imaging Market is expected to reach ~USD 9.4 billion in 2032 by growing at a CAGR of ~10%. Elastography imaging is a detailed diagnostic modality that is used in measuring tissue’s stiffness and elasticity for the purpose of diagnosing as well as managing different disease conditions based on the structural features of tissues. As a mechanical wave-based imaging method, elastography facilitates diagnosing tissue conditions without biopsy, especially for fibrosis, tumors, and musculoskeletal diseases. This technology entails techniques such as transient elastography and shear wave elastography, which are expanding on integration with real-time imaging, and artificial intelligence for improved diagnosing proficiency. Technological advancement in the trend of identifying diseases through non-invasive procedures and adopting patient-specific approaches, including disease diagnosis, has remained instrumental in the construction of elastography imaging across different practices.

Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=64448&utm_source=LinkSJ&utm_medium=Snehal&utm_campaign=Snehal&utm_id=snehal

KEY GROWTH DRIVERS:

Elastography imaging is part of the diagnostic imaging industry which is rapidly evolving in the healthcare market by using a high-frequency vibration to analyze tissue stiffness to diagnose and stage diseases like liver fibrosis, tumors, and musculoskeletal disorders. Artificial intelligence’s integration and optimization of software contribute to the advancements of elastography in terms of precision and speed. The market is growing owing to the increasing healthcare infrastructure in developing nations and the emphasis on the individualized approach to diseases. Company collaborations, acquisitions, and innovative product launches also drive the industry's growth.

The report suggests that the Increasing prevalence of chronic diseases is a significant factor driving the growth of the elastography imaging market in the coming years. According to the American Cancer Society’s estimates for primary liver cancer and intrahepatic bile duct cancer in the United States for 2024, about 41,630 new cases (28,000 in men and 13,630 in women) will be diagnosed with cancer and about 29,840 people (19,120 men and 10,720 women) will die of these cancers. According to the National Cancer Institute, in 2021, an estimated 3,972,256 women were living with female breast cancer in the United States. The growing incidence of fatty liver diseases, cancer, and cardiovascular diseases is a key factor for the elastography imaging market. As these conditions increase in occurrence, there is a need for diagnostic instruments that can accurately and noninvasively measure tissue stiffness and elasticity. Elastography imaging plays a very significant role in the early diagnosis, staging, and assessment of these chronic illnesses hence is widely used in current healthcare systems. This demand for an efficient and time-sensitive diagnostic method is impelling the development and usage of elastography in many fields of medicine.

Magnetic Resonance Elastography Segment Gaining Maximum Traction in the Market

Magnetic resonance elastography (MRE) is one of the segments of the elastography imaging market that is growing rapidly due to its enhanced capacity to deliver a highly resolved picture of the stiffness of tissues. MRE’s non-invasive modality and high spatial resolution make MRE primarily suitable for diagnosing and staging pathologies, such as liver fibrosis, tumors, and brain lesions where accurate measurement of the tissue elasticity is essential. Its growth is supported by the development of new technologies helping to improve imaging quality and accelerate the process, as well as by the growing use of the segment’s offerings in clinical practice due to the demand for better diagnostic means. Furthermore, the increase in incidence rates of chronic liver diseases and the realization of the need for early and targeted disease diagnosis through ME in the elastography market contributes to the sustained growth of MRE.

Ask for Report Customization - https://univdatos.com/get-a-free-sample-form-php/?product_id=64448&utm_source=LinkSJ&utm_medium=Snehal&utm_campaign=Snehal&utm_id=snehal

Browse Related Reports:

·        Asthma Disease Market

·        3D Cardiac Mapping System Market

·        Bone Void Fillers Market

·        Rheumatoid Arthritis Market

·        Oxycodone Market

Conclusion

The global elastography imaging market is rapidly growing, with advancements in the healthcare industry leading to improved outcomes. The global market is expected to increase as new innovative medical devices are developed in the coming years. Thus, the international elastography imaging market represents a significant opportunity for companies to make strategic alliances to launch efficient medical devices. With continued development,